New York, April 24, 2014 -- Moody's Investors Service placed Biomet, Inc.'s debt ratings (B2 CFR) under review for upgrade following news that the company has signed a definitive agreement to be acquired by Zimmer Holdings, Inc. for $13.35 billion. At the same time, Moody's affirmed Biomet's SGL-2 rating. Moody's understands that Zimmer intends to repay Biomet's debt. Assuming all of Biomet's existing debt is retired, the ratings will be withdrawn.

Vollständigen Artikel bei Moodys lesen